Orphazyme A/S buy me8
Start price
23.08.21
/
0%
€4.98
Target price
23.08.22
€7.00
Performance (%)
-17.27%
End price
04.09.21
€4.12
Summary
This prediction ended on 04.09.21 with a price of €4.12. The prediction for Orphazyme A/S disappointed with a performance of -17.27%. This prediction was marked as speculative and is excluded from me8's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Orphazyme A/S | - | - | - | - |
| iShares Core DAX® | -0,87 % | 5,32 % | 6,86 % | 65,21 % |
| iShares Nasdaq 100 | -0,38 % | 1,98 % | 25,70 % | 90,33 % |
| iShares Nikkei 225® | -1,68 % | 1,95 % | 41,44 % | 80,62 % |
| iShares S&P 500 | -0,65 % | 2,07 % | 21,40 % | 70,74 % |
According to me8 what are the pros and cons of Orphazyme A/S for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Good culture
Capable Management
Cons
Little innovation
Comments by me8 for this prediction
In the thread Orphazyme A/s diskutieren
Buy Orphazyme A/S
Kursziel gesetzt auf 7,0
In the thread Trading Orphazyme A/s
Einschätzung wurde nach dem Ende von Catch the Monkey automatisch beendet.